Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur SonoVue® 8 μL/mL:Bracco Suisse SA
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
V08DA05 - Sulfur Hexafluoride, Phospholipid MicrospheresATC-DDD Version 2016. Source: WHO
V - Various

This group comprises many different types of drugs, and assigning DDDs are difficult. Very few DDDs are assigned in this group.

V08 - Contrast Media

This group comprises X-ray, MRI and Ultrasound contrast media. The X-ray contrast media are subdivided into iodinated and non-iodinated compounds, and are further classified according to water solubility, osmolarity and nephrotropic/hepatotropic properties. High osmolar substances correspond mainly to ionic substances, except from ioxaglic acid, which is classified together with the non-ionic substances. MRI contrast media are subdivided according to magnetic properties.

V08D - Ultrasound Contrast Media
V08DA - Ultrasound Contrast Media

The microspheres may contain various ingredients. E.g. perflutren suspension in microspheres of phospholipids is classfied in V08DA04.
Perflenapent covers structural isomers of dodecafluoropentane i.e. perflisopent.

V08DA05 - Sulfur Hexafluoride, Phospholipid Microspheres
2020 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home